Standout Papers
- Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial (2014)
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial (2016)
Immediate Impact
1 by Nobel laureates 4 from Science/Nature 50 standout
Citing Papers
Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke Therapy
2024 Standout
National, regional, and global estimates of low birthweight in 2020, with trends from 2000: a systematic analysis
2024 Standout
Works of Bingbing Li being referenced
Folic Acid and Risk of Preterm Birth: A Meta-Analysis
2019
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
2014 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Bingbing Li | 573 | 93 | 83 | 873 | 358 | 56 | 1.6k | |
| Christian P. Kamm | 389 | 22 | 31 | 1102 | 356 | 93 | 1.7k | |
| Paola Zaratin | 660 | 40 | 31 | 838 | 343 | 74 | 2.2k | |
| Stanley Cohan | 309 | 58 | 151 | 566 | 275 | 92 | 1.6k | |
| Carlo Avolio | 387 | 37 | 53 | 659 | 272 | 72 | 1.7k | |
| Bardia Nourbakhsh | 262 | 20 | 29 | 835 | 346 | 56 | 1.4k | |
| Jayne Ness | 353 | 101 | 56 | 1149 | 846 | 44 | 2.0k | |
| Martin Gunnarsson | 318 | 33 | 99 | 1368 | 639 | 46 | 2.0k | |
| Giuseppe Fenu | 207 | 17 | 29 | 969 | 327 | 90 | 1.5k | |
| Adam Kaplin | 631 | 35 | 60 | 421 | 390 | 44 | 1.9k | |
| Carolina Ionete | 470 | 18 | 83 | 472 | 245 | 50 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...